Milken Institute Center To Study FDA Approval Process, Innovation Strategies
This article was originally published in The Gray Sheet
Executive Summary
The Milken Institute's Center for Accelerating Medical Solutions hopes to begin operations in Washington, D.C. during the summer
You may also be interested in...
QS Initiative Gains Significance In 2003 Budget Crunch – McClellan
FDA's quality systems improvement initiative is the vehicle by which Commissioner Mark McClellan hopes to leverage substantial device review reforms from CDRH's FY 2003 appropriation of $208 mil
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.